Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Disease Outlook
1.2.2. Regional Scope
1.2.3. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Disease Outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Enteric Diseases Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Enteric Diseases Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
Chapter 4. Enteric Diseases Testing: Disease Estimates & Trend Analysis
4.1. Disease Segment Dashboard
4.2. Enteric Diseases Testing Market: Industry Movement Analysis
4.3. Global Enteric Diseases Testing Market Size & Trend Analysis, by Disease , 2018 to 2030 (USD Million)
4.4. Bacterial
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. C. Difficile
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Campylobacteriosis
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Cholera
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. E. Coli
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. H. Pylori
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Salmonellosis
4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.8. Shigellosis
4.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Viral
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Rotavirus
4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Norovirus
4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Parasitic
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Amebiasis
4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Cryptosporidiosis
4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Giardiasis
4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Enteric Diseases Testing Market: Regional Estimates & Trend Analysis
5.1. Regional Market Dashboard
5.2. Regional Market Share Analysis, 2024 & 2030
5.3. Continuous bioprocessing market by Region: Key Takeaways
5.4. North America
5.4.1. U.S.
5.4.1.1. Key country dynamics
5.4.1.2. Regulatory framework/ reimbursement structure
5.4.1.3. Competitive scenario
5.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Canada
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Mexico
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Europe
5.5.1. UK
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
5.5.2. Germany
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
5.5.3. France
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework/ reimbursement structure
5.5.3.3. Competitive scenario
5.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
5.5.4. Italy
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework/ reimbursement structure
5.5.4.3. Competitive scenario
5.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
5.5.5. Spain
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework/ reimbursement structure
5.5.5.3. Competitive scenario
5.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
5.5.6. Norway
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework/ reimbursement structure
5.5.6.3. Competitive scenario
5.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
5.5.7. Sweden
5.5.7.1. Key country dynamics
5.5.7.2. Regulatory framework/ reimbursement structure
5.5.7.3. Competitive scenario
5.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
5.5.8. Denmark
5.5.8.1. Key country dynamics
5.5.8.2. Regulatory framework/ reimbursement structure
5.5.8.3. Competitive scenario
5.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Asia Pacific
5.6.1. Japan
5.6.1.1. Key country dynamics
5.6.1.2. Regulatory framework/ reimbursement structure
5.6.1.3. Competitive scenario
5.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
5.6.2. China
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
5.6.3. India
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework/ reimbursement structure
5.6.3.3. Competitive scenario
5.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
5.6.4. Australia
5.6.4.1. Key country dynamics
5.6.4.2. Regulatory framework/ reimbursement structure
5.6.4.3. Competitive scenario
5.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
5.6.5. South Korea
5.6.5.1. Key country dynamics
5.6.5.2. Regulatory framework/ reimbursement structure
5.6.5.3. Competitive scenario
5.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
5.6.6. Thailand
5.6.6.1. Key country dynamics
5.6.6.2. Regulatory framework/ reimbursement structure
5.6.6.3. Competitive scenario
5.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Latin America
5.7.1. Brazil
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework/ reimbursement structure
5.7.1.3. Competitive scenario
5.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
5.7.2. Argentina
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
5.8. MEA
5.8.1. South Africa
5.8.1.1. Key country dynamics
5.8.1.2. Regulatory framework/ reimbursement structure
5.8.1.3. Competitive scenario
5.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
5.8.2. Saudi Arabia
5.8.2.1. Key country dynamics
5.8.2.2. Regulatory framework/ reimbursement structure
5.8.2.3. Competitive scenario
5.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
5.8.3. UAE
5.8.3.1. Key country dynamics
5.8.3.2. Regulatory framework/ reimbursement structure
5.8.3.3. Competitive scenario
5.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
5.8.4. Kuwait
5.8.4.1. Key country dynamics
5.8.4.2. Regulatory framework/ reimbursement structure
5.8.4.3. Competitive scenario
5.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, by Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. Key company heat map analysis, 2024
6.4. Company Profiles
6.4.1. Abbott
6.4.1.1. Company overview
6.4.1.2. Financial performance
6.4.1.3. Product benchmarking
6.4.1.4. Strategic initiatives
6.4.2. BD
6.4.2.1. Company overview
6.4.2.2. Financial performance
6.4.2.3. Product benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Biomerica
6.4.3.1. Company overview
6.4.3.2. Financial performance
6.4.3.3. Product benchmarking
6.4.3.4. Strategic initiatives
6.4.4. BIOMÉRIEUX
6.4.4.1. Company overview
6.4.4.2. Financial performance
6.4.4.3. Product benchmarking
6.4.4.4. Strategic initiatives
6.4.5. Bio-Rad Laboratories, Inc.
6.4.5.1. Company overview
6.4.5.2. Financial performance
6.4.5.3. Product benchmarking
6.4.5.4. Strategic initiatives
6.4.6. Cepheid
6.4.6.1. Company overview
6.4.6.2. Financial performance
6.4.6.3. Product benchmarking
6.4.6.4. Strategic initiatives
6.4.7. Coris Bioconcept
6.4.7.1. Company overview
6.4.7.2. Financial performance
6.4.7.3. Product benchmarking
6.4.7.4. Strategic initiatives
6.4.8. DiaSorin S.p.A.
6.4.8.1. Company overview
6.4.8.2. Financial performance
6.4.8.3. Product benchmarking
6.4.8.4. Strategic initiatives
6.4.9. Meridian Bioscience
6.4.9.1. Company overview
6.4.9.2. Financial performance
6.4.9.3. Product benchmarking
6.4.9.4. Strategic initiatives
6.4.10. Quest Diagnostics Incorporated
6.4.10.1. Company overview
6.4.10.2. Financial performance
6.4.10.3. Product benchmarking
6.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America enteric disease testing market, by country, 2018-2030 (USD Million)
Table 3 North America enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 4 U.S. enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 5 Canada enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 6 Mexico enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 7 Europe enteric disease testing market, by country, 2018-2030 (USD Million)
Table 8 Europe enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 9 UK enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 10 Germany enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 11 France enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 12 Italy enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 13 Spain enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 14 Denmark enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 15 Sweden enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 16 Norway enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 17 Asia Pacific enteric disease testing market, by country, 2018-2030 (USD Million)
Table 18 Asia Pacific enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 19 China enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 20 Japan enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 21 India enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 22 Australia enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 23 South Korea enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 24 Thailand enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 25 Latin America enteric disease testing market, by country, 2018-2030 (USD Million)
Table 26 Latin America enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 27 Brazil enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 28 Argentina enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 29 Middle East & Africa enteric disease testing market, by country, 2018-2030 (USD Million)
Table 30 Middle East & Africa enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 31 South Africa enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 32 Saudi Arabia enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 33 UAE enteric disease testing market, by disease, 2018-2030 (USD Million)
Table 34 Kuwait enteric disease testing market, by disease, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Enteric disease testing market: market outlook
Figure 10 Enteric disease competitive insights
Figure 11 Parent market outlook
Figure 12 Related/ancillary market outlook
Figure 13 Penetration and growth prospect mapping
Figure 14 Industry value chain analysis
Figure 15 Enteric disease testing market driver impact
Figure 16 Enteric disease testing market restraint impact
Figure 17 Enteric disease testing market strategic initiatives analysis
Figure 18 Global enteric disease testing market: Disease movement analysis
Figure 19 Global enteric disease testing market: Disease outlook and key takeaways
Figure 20 Bacterial enteric disease testing market estimates and forecast, 2018-2030
Figure 21 Viral enteric disease testing market estimates and forecast, 2018-2030
Figure 22 Rotavirus testing market estimates and forecast, 2018-2030
Figure 23 Norovirus testing market estimates and forecast, 2018-2030
Figure 24 Parasitic enteric disease testing market estimates and forecast, 2018-203
Figure 25 Global enteric disease testing market: Regional movement analysis
Figure 26 Global enteric disease testing market: Regional outlook and key takeaways
Figure 27 North America enteric disease testing market estimates and forecasts, 2018-2030
Figure 28 U.S. enteric disease testing market estimates and forecasts, 2018-2030
Figure 29 Canada enteric disease testing market estimates and forecasts, 2018-2030
Figure 30 Mexico enteric disease testing market estimates and forecasts, 2018-2030
Figure 31 Europe enteric disease testing market estimates and forecasts, 2018-2030
Figure 32 UK enteric disease testing market estimates and forecasts, 2018-2030
Figure 33 Germany enteric disease testing market estimates and forecasts, 2018-2030
Figure 34 France enteric disease testing market estimates and forecasts, 2018-2030
Figure 35 Italy enteric disease testing market estimates and forecasts, 2018-2030
Figure 36 Spain enteric disease testing market estimates and forecasts, 2018-2030
Figure 37 Denmark enteric disease testing market estimates and forecasts, 2018-2030
Figure 38 Sweden enteric disease testing market estimates and forecasts, 2018-2030
Figure 39 Norway enteric disease testing market estimates and forecasts, 2018-2030
Figure 40 Asia Pacific enteric disease testing market estimates and forecasts, 2018-2030
Figure 41 China enteric disease testing market estimates and forecasts, 2018-2030
Figure 42 Japan enteric disease testing market estimates and forecasts, 2018-2030
Figure 43 India enteric disease testing market estimates and forecasts, 2018-2030
Figure 44 Thailand enteric disease testing market estimates and forecasts, 2018-2030
Figure 45 South Korea enteric disease testing market estimates and forecasts, 2018-2030
Figure 46 Australia enteric disease testing market estimates and forecasts, 2018-2030
Figure 47 Latin America enteric disease testing market estimates and forecasts, 2018-2030
Figure 48 Brazil enteric disease testing market estimates and forecasts, 2018-2030
Figure 49 Argentina enteric disease testing market estimates and forecasts, 2018-2030
Figure 50 Middle East and Africa enteric disease testing market estimates and forecasts, 2018-2030
Figure 51 South Africa enteric disease testing market estimates and forecasts, 2018-2030
Figure 52 Saudi Arabia enteric disease testing market estimates and forecasts, 2018-2030
Figure 53 UAE enteric disease testing market estimates and forecasts, 2018-2030
Figure 54 Kuwait enteric disease testing market estimates and forecasts, 2018-2030
